MAPT and Alzheimer disease: Additionally, Western blotting results showed no significant differences in Calb1 protein levels between the WT and P301L groups (Fig. S4), indicating that there is no transformation of Calb1 + neurons into Calb1− neurons at the early stage of AD-like tau pathology.